Fengna Yan

446 total citations
13 papers, 274 citations indexed

About

Fengna Yan is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Fengna Yan has authored 13 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Fengna Yan's work include Liver Disease Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Fengna Yan is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Fengna Yan collaborates with scholars based in China, Uganda and United States. Fengna Yan's co-authors include Youping Wang, Si Shen, Lin Cui, Xinhui Wang, Xiaoli Liu, Mingjun Zhu, Hui Xu, Lihua Yu, Peng Wang and Yuyong Jiang and has published in prestigious journals such as Journal of Ethnopharmacology, Atherosclerosis and BMC Cancer.

In The Last Decade

Fengna Yan

13 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengna Yan China	9	92	71	56	42	36	13	274
Wen Tian China	13	152 1.7×	54 0.8×	23 0.4×	31 0.7×	18 0.5×	28	327
Hongmei Piao China	11	139 1.5×	113 1.6×	32 0.6×	34 0.8×	25 0.7×	18	365
Lihong Wang China	10	166 1.8×	60 0.8×	35 0.6×	42 1.0×	14 0.4×	14	384
Zhulan Cai China	12	251 2.7×	62 0.9×	26 0.5×	53 1.3×	44 1.2×	16	425
Yongxiang Gao China	10	144 1.6×	36 0.5×	20 0.4×	26 0.6×	46 1.3×	28	308
Dong-Gyu Kim South Korea	10	123 1.3×	33 0.5×	30 0.5×	19 0.5×	20 0.6×	25	355
Yihong Lai China	9	114 1.2×	69 1.0×	64 1.1×	24 0.6×	21 0.6×	10	334
Qingqing Ruan China	8	113 1.2×	64 0.9×	27 0.5×	111 2.6×	19 0.5×	14	384
Xi Hong China	10	129 1.4×	38 0.5×	64 1.1×	28 0.7×	5 0.1×	25	376
Yan Qin Tan Hong Kong	10	126 1.4×	35 0.5×	56 1.0×	24 0.6×	14 0.4×	21	278

Countries citing papers authored by Fengna Yan

Since Specialization

Citations

This map shows the geographic impact of Fengna Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengna Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengna Yan more than expected).

Fields of papers citing papers by Fengna Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengna Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengna Yan. The network helps show where Fengna Yan may publish in the future.

Co-authorship network of co-authors of Fengna Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Fengna Yan. A scholar is included among the top collaborators of Fengna Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengna Yan. Fengna Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Xie, Yuqing, et al.. (2025). FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription. Drug Design Development and Therapy. Volume 19. 1543–1560. 1 indexed citations

Xie, Yuqing, et al.. (2024). Mechanism of Shashen-Maidong herb pair in treating hepatocellular carcinoma using network pharmacology and experimental validation. Journal of Ethnopharmacology. 337(Pt 3). 118954–118954. 2 indexed citations

Yan, Fengna, Bingbing Zhu, Ke Shi, et al.. (2024). Prognostic and therapeutic potential of imbalance between PD‐1+CD8 and ICOS+Treg cells in advanced HBV‐HCC. Cancer Science. 115(8). 2553–2564. 4 indexed citations

Yan, Fengna, Qun Zhang, Ke Shi, et al.. (2023). Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response. Frontiers in Cellular and Infection Microbiology. 13. 1152987–1152987. 38 indexed citations

Wang, Peng, Xinhui Wang, Xiaoli Liu, et al.. (2023). Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma. BMC Cancer. 23(1). 564–564. 1 indexed citations

Xie, Yuqing, Fengna Yan, Xinhui Wang, et al.. (2022). Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma. Cancer Medicine. 12(3). 3237–3259. 8 indexed citations

Wang, Xinhui, Xiaoli Liu, Peng Wang, et al.. (2021). Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia. Journal of Hepatocellular Carcinoma. Volume 8. 1253–1267. 9 indexed citations

Yan, Fengna, Xinhui Wang, Yuqing Xie, et al.. (2021). Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells. Phytomedicine. 91. 153722–153722. 13 indexed citations

Zhou, Dongdong, Xiaoli Liu, Xinhui Wang, et al.. (2021). A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer. 21(1). 246–246. 22 indexed citations

10.

Yu, Lihua, Xiaoli Liu, Xinhui Wang, et al.. (2021). TIGIT ⁺ TIM-3 ⁺ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma. OncoImmunology. 10(1). 1942673–1942673. 49 indexed citations

11.

Yan, Fengna, Miaomiao Feng, Xinhui Wang, et al.. (2020). Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysis. Cancer Cell International. 20(1). 540–540. 11 indexed citations

12.

Wang, Youping, et al.. (2019). Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway. BMC Complementary and Alternative Medicine. 19(1). 198–198. 27 indexed citations

13.

Wang, Youping, Lin Cui, Hui Xu, et al.. (2017). TRPV1 agonism inhibits endothelial cell inflammation via activation of eNOS/NO pathway. Atherosclerosis. 260. 13–19. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact